Citadel Advisors’s Inspire Corporate Bond ETF IBD Stock Holding History
Bought
Maintained
Sold
Other funds holding IBD
IA
FA
CFD
II
BFS
OFS
CW
PFG
PAW
Citadel Advisors's IBD Position: Q1 2026 in Review
Citadel Advisors increased its Inspire Corporate Bond ETF (IBD) stake by 364% in Q1 2026, buying an estimated $4.33M and bringing the position to 228,764 shares worth $5.46M. The position accounts for ﹤0.01% of the portfolio, ranked #4203.
Citadel Advisors first reported a position in IBD in Q4 2019 and has held it in 19 quarters since. The position peaked at $6.29M in Q2 2021. 106 funds tracked by Wall St. Rank hold IBD as of Q1 2026.
- Citadel Advisors held 228,764 shares of Inspire Corporate Bond ETF worth $5.46M as of Q1 2026.
- Citadel Advisors bought 179,513 Inspire Corporate Bond ETF shares in Q1 2026, an estimated $4.33M.
- Inspire Corporate Bond ETF made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #4203 holding.
- Citadel Advisors first reported a position in Inspire Corporate Bond ETF in Q4 2019 and has held it in 19 quarters since.
- Citadel Advisors's Inspire Corporate Bond ETF position peaked at $6.29M in Q2 2021.
- 106 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.